Ngā hua rapu - Lisa Miller‐Phillips

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

    FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial mā Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Florian Kaiser, Salah-Edin Al-Batran, Tobias Heintges, Christoph Lerchenmüller, Christoph Kahl, G. Seipelt, Frank Kullmann, Markus Moehler, Werner Scheithauer, Swantje Held, Lisa Miller‐Phillips, Dominik Paul Modest, Andreas Jung, Thomas Kirchner, Sebastian Stintzing

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

    Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board mā Kathrin Heinrich, Lisa Miller‐Phillips, Frank Ziemann, Korbinian Hasselmann, Katharina Rühlmann, Madeleine Flach, Dorottya Biro, Michael von Bergwelt‐Baildon, Julian Walter Holch, Tobias Herold, Louisa von Baumgarten, Philipp A. Greif, Irmela Jeremias, Rachel Wuerstlein, Jozefina Casuscelli, Christine Spitzweg, Max Seidensticker, Bernhard W. Renz, Stefanie Corradini, Philipp Baumeister, Elisabetta Goni, Amanda Tufman, Andreas Jung, Jörg Kumbrink, Thomas Kirchner, Frederick Klauschen, Klaus H. Metzeler, Volker Heinemann, C. Benedikt Westphalen

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: